- Home
- WNC vs RCKT Comparison
WNC vs RCKT Comparison
Compare WNC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WNC | RCKT |
|---|---|---|
| Founded | 1985 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.2M | 534.2M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | WNC | RCKT |
|---|---|---|
| Price | $8.18 | $4.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $11.00 | ★ $29.65 |
| AVG Volume (30 Days) | 494.5K | ★ 2.9M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | ★ 179.22 | N/A |
| EPS | ★ 5.07 | N/A |
| Revenue | ★ $2,027,489,000.00 | N/A |
| Revenue This Year | $0.53 | N/A |
| Revenue Next Year | $25.53 | $97.68 |
| P/E Ratio | $1.61 | ★ N/A |
| Revenue Growth | ★ 8.81 | N/A |
| 52 Week Low | $6.78 | $2.19 |
| 52 Week High | $12.94 | $8.80 |
Technical Indicators
Market Signals| Indicator | WNC | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 26.60 | 58.97 |
| Support Level | N/A | $2.99 |
| Resistance Level | $11.74 | $5.34 |
| Average True Range (ATR) | 0.44 | 0.38 |
| MACD | -0.23 | -0.00 |
| Stochastic Oscillator | 6.27 | 51.16 |
Price Performance
Historical ComparisonAbout WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.